摘要: In the USA, mass opportunistic screening has resulted in increased detection of prostate cancer and an proportion patients who are candidates for curative therapy. Screening also low-risk cancers that may pose a relatively low threat to survival quality life, particularly with limited life expectancy. No treatment been definitively proven be superior another terms quantity life. However, all definitive treatments (radical prostatectomy, EBRT, brachytherapy) negatively impact urinary, bowel, sexual function. As there substantial trade-offs between benefits risks likely sensitive patient preferences, it is recommended informed potential options adherence published guidelines. general, underutilization active surveillance, those Radical prostatectomy external-beam radiotherapy 2–3 years adjuvant androgen deprivation therapy standard high-risk disease. The outcomes undergoing local favorable, risk clinical disease progression serious morbidity. Outcomes appear expertise skill treating urologist oncologist.
springer.com
springerlink.com参考文章(115)
Colleen A. Lawton, Michelle DeSilvio, Mack Roach, Valery Uhl, Robert Kirsch, Michael Seider, Marvin Rotman, Christopher Jones, Sucha Asbell, Richard Valicenti, Stephen Hahn, Charles R. Thomas, An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions International Journal of Radiation Oncology Biology Physics. ,vol. 69, pp. 646- 655 ,(2007) , 10.1016/J.IJROBP.2007.04.003
Joseph A. Smith, Robert C. Chan, Sam S. Chang, S. Duke Herrell, Peter E. Clark, Roxy Baumgartner, Michael S. Cookson, A Comparison of the Incidence and Location of Positive Surgical Margins in Robotic Assisted Laparoscopic Radical Prostatectomy and Open Retropubic Radical Prostatectomy Journal of Urology. ,vol. 178, pp. 2385- 2390 ,(2007) , 10.1016/J.JURO.2007.08.008
Patrick A Kupelian, Louis Potters, Deepak Khuntia, Jay P Ciezki, Chandana A Reddy, Alwyn M Reuther, Thomas P Carlson, Eric A Klein, Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer International Journal of Radiation Oncology Biology Physics. ,vol. 58, pp. 25- 33 ,(2002) , 10.1016/S0360-3016(03)00784-3
M.W. Kattan, Expert Systems in Medicine International Encyclopedia of the Social & Behavioral Sciences. pp. 5135- 5139 ,(2001) , 10.1016/B0-08-043076-7/00556-8
Karim Touijer, Javier Romero Otero, Fernando P. Secin, Rafael Sanchez Salas, Jason Stasi, James A. Eastham, Peter T. Scardino, Bertrand Guillonneau, 553: Comprehensive Prospective Comparative Analysis of Outcomes between Open and Laparoscopic Radical Prostatectomy The Journal of Urology. ,vol. 177, pp. 184- 184 ,(2007) , 10.1016/S0022-5347(18)30793-6
Stephen J. Freedland, Elizabeth B. Humphreys, Leslie A. Mangold, Mario Eisenberger, Frederick J. Dorey, Patrick C. Walsh, Alan W. Partin, Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy JAMA. ,vol. 294, pp. 433- 439 ,(2005) , 10.1001/JAMA.294.4.433
James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh, Prostate cancer. Clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network. ,vol. 8, pp. 162- 200 ,(2010) , 10.6004/JNCCN.2010.0012
G D Chisholm, R F Deane, G B McKelvie, C D Rennie, E L Gilliland, C P Chilton, M G Royle, N H Townell, J Breakey, S M Cresswell, J Glaholm, G M Sole, J J Bolger, M J Stower, M H Ashken, D A Tolley, F J Bramble, P A Jones, R A Styles, Moffat Lef., R W Glashan, Rhind, A Radley, G J Fellows, J Crowther, B Hafner, S Knight, E Thompson, J Smith, J Burrett, P B Clark, J Boreham, R Peto, L N Jurczyk, B A DeSousa, S Parish, Logie Jrc., Ross Rta., Cox, K Perry, T P Stephenson, K K Sethia, Turner Dtl., M Davies, Harrison Gsm., G F Carswell, Rogers Acn., M Lucas, M R Heal, V Boag, J Hetherington, D Kirk, Charlton Cac., Shepheard Bgf., N A Green, M F Smith, T B Hargreave, Moore Kth., R J Morgan, K N Bullock, Bevis Cra., J B Anderson, A L Stewart, Newling Dwk., B Richards, Grayson Cea., Gaches Cgc., P T Doyle, Robinson Mrg., S Sagar, R J Shearer, C M Evans, R A Jones, Wightman Jak., E R Coulton, J C Smith, M E French, C S Powell, Fernie Cgm., Orr Pgg., M Claridge, Gallegos Crr., G H Urwin, G M Watson, C Roberts, S Griffin, M B Rose, M Fordham, G S Watson, W T Lawrence, R Pollard, P H Smith, M J James, Grant Jbp., J P Ward, R R Hall, M Hehir, J L Williams, R W Thomson, L L Beynon, R J Luck, R Rampling, R S Adib, P English, A McGregor, C D Baumber, J W Blaxland, M H Devereux, R Clack, Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial BJUI. ,vol. 79, pp. 235- 246 ,(1997)
Michael W. Kattan, Thomas M. Wheeler, Peter T. Scardino, Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1499- 1499 ,(1999) , 10.1200/JCO.1999.17.5.1499